This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Chinese Academy of Sciences, Vigonvita Life Sciences Co., Ltd., Shanghai Institute of Materia Medica, Chines Academy of Sciences. Active years: 2024-2026.
Company Filing History:
6 out of 3,346 
2 out of 2 
1 out of 1 Years Active: 2024-2026
Title: Gengfu Xiao: Innovator in Antiviral Applications
Introduction
Gengfu Xiao is a notable inventor based in Wuhan, China. He has made significant contributions to the field of antiviral research, particularly through his innovative use of nucleoside analogs. With a total of two patents to his name, his work focuses on developing effective treatments for viral infections.
Latest Patents
Gengfu Xiao's latest patents revolve around the antiviral application of nucleoside analogs. These inventions detail the use of nucleoside analogs and pharmaceutical compositions as inhibitors for the replication of various viruses, including coronaviruses, influenza viruses, and others. His research aims to provide medicines that treat, prevent, and mitigate diseases caused by these viral infections, including COVID-19 and pneumonia.
Career Highlights
Throughout his career, Gengfu Xiao has worked with esteemed organizations such as the Chinese Academy of Sciences and Vigonvita Life Sciences Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Gengfu Xiao has collaborated with notable colleagues, including Yuanchao Xie and Yang He. These partnerships have further enriched his research endeavors and have played a role in the development of his innovative solutions.
Conclusion
Gengfu Xiao's work in antiviral applications showcases his dedication to addressing critical health challenges. His inventions have the potential to significantly impact the treatment of viral infections, making him a key figure in the field of medical innovation.